{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:57:25Z","timestamp":1791280645877,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/jhh.2015.103","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T09:22:04Z","timestamp":1444296124000},"page":"368-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation"],"prefix":"10.1038","volume":"30","author":[{"given":"P","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P K C","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M J","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A G","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tomaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"key":"BFjhh2015103_CR1","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","volume":"57","author":"A de la Sierra","year":"2011","unstructured":"de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57: 898\u2013902.","journal-title":"Hypertension"},{"key":"BFjhh2015103_CR2","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","volume":"125","author":"SL Daugherty","year":"2012","unstructured":"Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012; 125: 1635\u20131642.","journal-title":"Circulation"},{"key":"BFjhh2015103_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/ajh\/hpt132","volume":"12","author":"SS Hayek","year":"2013","unstructured":"Hayek SS, Abdou MH, Demoss BD, Legaspi JM, Veledar E, Deka A et al. Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients. Am J Hypertens 2013; 12: 1452\u20131458.","journal-title":"Am J Hypertens"},{"key":"BFjhh2015103_CR4","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/CIRCRESAHA.116.303603","volume":"116","author":"S Oparil","year":"2015","unstructured":"Oparil S, Schmieder RE . New approaches in the treatment of hypertension. Circ Res 2015; 116: 1074\u20131095.","journal-title":"Circ Res"},{"key":"BFjhh2015103_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/HYPERTENSIONAHA.113.02026","volume":"63","author":"DA Calhoun","year":"2014","unstructured":"Calhoun DA, Booth JN 3rd, Oparil S, Irvin MR, Shimbo D, Lackland DT et al. Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension 2014; 63: 451\u2013458.","journal-title":"Hypertension"},{"key":"BFjhh2015103_CR6","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/HYPERTENSIONAHA.114.03850","volume":"64","author":"P Muntner","year":"2014","unstructured":"Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL et al. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2014; 64: 1012\u20131021.","journal-title":"Hypertension"},{"key":"BFjhh2015103_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275\u20131281.","journal-title":"Lancet"},{"key":"BFjhh2015103_CR8","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"MD Esler","year":"2010","unstructured":"Symplicity HTN-2 Investigators Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903\u20131909.","journal-title":"Lancet"},{"key":"BFjhh2015103_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","volume":"57","author":"Symplicity HTN-1 Investigators","year":"2011","unstructured":"Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011; 57: 911\u2013917.","journal-title":"Hypertension"},{"key":"BFjhh2015103_CR10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393\u20131401.","journal-title":"N Engl J Med"},{"key":"BFjhh2015103_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/heartjnl-2014-307029","volume":"101","author":"MD Lobo","year":"2015","unstructured":"Lobo MD, de Belder MA, Cleveland T, Collier D, Dasgupta I, Deanfield J et al. British Hypertension Society; British Cardiovascular Society; British Cardiovascular Intervention Society; Renal Association. Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension. Heart 2015; 101: 10\u201316.","journal-title":"Heart"},{"key":"BFjhh2015103_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/HJH.0b013e328352ce78","volume":"30","author":"RE Schmieder","year":"2012","unstructured":"Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K et al. ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens 2012; 30: 837\u2013841.","journal-title":"J Hypertens"},{"key":"BFjhh2015103_CR13","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.114.03194","volume":"63","author":"A Persu","year":"2014","unstructured":"Persu A, Jin Y, Baelen M, Vink E, Verloop WL, Schmidt B et al. Eligibility for renal denervation: experience at 11 European expert centers. Hypertension 2014; 63: 1319\u20131325.","journal-title":"Hypertension"},{"key":"BFjhh2015103_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/08037051.2013.867655","volume":"23","author":"LK Olsen","year":"2014","unstructured":"Olsen LK, Kamper AL, Svendsen JH, Bang LE, Frimodt-Moller M, Kelbaek H et al. High incidence of secondary hypertension in patients referred for renal denervation\u2014the Copenhagen experience. Blood Press 2014; 23: 233\u2013239.","journal-title":"Blood Press"},{"key":"BFjhh2015103_CR15","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.jacc.2012.08.1002","volume":"60","author":"S Savard","year":"2012","unstructured":"Savard S, Frank M, Bobrie G, Plouin PF, Sapoval M, Azizi M . Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients. J Am Coll Cardiol 2012; 60: 2422\u20132424.","journal-title":"J Am Coll Cardiol"},{"key":"BFjhh2015103_CR16","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1097\/HJH.0b013e328362152e","volume":"31","author":"WL Verloop","year":"2013","unstructured":"Verloop WL, Vink EE, Voskuil M, Vonken EJ, Rookmaaker MB, Bots ML et al. Eligibility for percutaneous renal denervation: the importance of a systematic screening. J Hypertens 2013; 31: 1662\u20131668.","journal-title":"J Hypertens"},{"key":"BFjhh2015103_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jacc.2013.10.067","volume":"63","author":"S Brinker","year":"2014","unstructured":"Brinker S, Pandey A, Ayers C, Price A, Raheja P, Arbique D et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J Am Coll Cardiol 2014; 63: 834\u2013835.","journal-title":"J Am Coll Cardiol"},{"key":"BFjhh2015103_CR18","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/j.ijcard.2013.12.181","volume":"172","author":"AD de Oliveira-Filho","year":"2014","unstructured":"de Oliveira-Filho AD, Costa FA, Neves SJ, de Lyra Junior DP, Morisky DE . Pseudoresistant hypertension due to poor medication adherence. Int J Cardiol 2014; 172: e309\u2013e310.","journal-title":"Int J Cardiol"},{"key":"BFjhh2015103_CR19","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1093\/ndt\/gfu330","volume":"30","author":"EO Gosmanova","year":"2015","unstructured":"Gosmanova EO, Kovesdy CP . Adherence to antihypertensive medications: is prescribing the right pill enough? Nephrol Dial Transplant 2015; 30: 1649\u20131656.","journal-title":"Nephrol Dial Transplant"},{"key":"BFjhh2015103_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/heartjnl-2013-305063","volume":"100","author":"M Tomaszewski","year":"2014","unstructured":"Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS\/MS) urine analysis. Heart 2014; 100: 855\u2013861.","journal-title":"Heart"},{"key":"BFjhh2015103_CR21","unstructured":"NICECG127 Hypertension: Clinical management of primary hypertension in adults 2011. http:\/\/www.nice.org.uk\/CG127 . Accessed 19 December 2014."},{"key":"BFjhh2015103_CR22","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1136\/bmj.e181","volume":"344","author":"RJ McManus","year":"2012","unstructured":"McManus RJ, Caulfield M, Williams B . National Institute for Health and Clinical Excellence. NICE hypertension guideline 2011: evidence based evolution. BMJ 2012; 344: e181.","journal-title":"BMJ"},{"key":"BFjhh2015103_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461\u2013470.","journal-title":"Ann Intern Med"},{"key":"BFjhh2015103_CR24","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","volume":"385","author":"M Azizi","year":"2015","unstructured":"Azizi M, Sapoval MG, Gosse P, Monge M, Bobrie G, Delsart P et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 2015; 385: 1957\u20131965.","journal-title":"Lancet"},{"key":"BFjhh2015103_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/HYPERTENSIONAHA.114.04019","volume":"65","author":"J Rosa","year":"2015","unstructured":"Rosa J, Widimsky P, Tousek P, Petrak O, Curila K, Waldauf P et al. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study. Hypertension 2015; 65: 407\u2013413.","journal-title":"Hypertension"},{"key":"BFjhh2015103_CR26","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/jhh.2014.3","volume":"28","author":"J Rosa","year":"2014","unstructured":"Rosa J, Zelinka T, Petrak O, Strauch B, Somloova Z, Indra T et al. Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically? J Hum Hypertens 2014; 28: 684\u2013688.","journal-title":"J Hum Hypertens"},{"key":"BFjhh2015103_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00126097-200212000-00001","volume":"7","author":"TG Pickering","year":"2002","unstructured":"Pickering TG, Gerin W, Schwartz AR . What is the white-coat effect and how should it be measured? Blood Press Monit 2002; 7: 293\u2013300.","journal-title":"Blood Press Monit"},{"key":"BFjhh2015103_CR28","first-page":"573","volume":"52","author":"M Tomaszewski","year":"1999","unstructured":"Tomaszewski M, Lacka B, Zukowska-Szczechowska E, Grzeszczak W, Gosek K . The evaluation of hypertensive patients' adherence to the pharmacological treatment of hypertension. Wiad Lek 1999; 52: 573\u2013580.","journal-title":"Wiad Lek"},{"key":"BFjhh2015103_CR29","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1097\/HJH.0000000000000346","volume":"32","author":"O Chung","year":"2014","unstructured":"Chung O, Vongpatanasin W, Bonaventura K, Lotan Y, Sohns C, Haverkamp W et al. Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension. J Hypertens 2014; 32: 2411\u20132421.","journal-title":"J Hypertens"},{"key":"BFjhh2015103_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/sj.jhh.1001721","volume":"18","author":"S Ross","year":"2004","unstructured":"Ross S, Walker A, MacLeod MJ . Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens 2004; 18: 607\u2013613.","journal-title":"J Hum Hypertens"},{"key":"BFjhh2015103_CR31","first-page":"CD004804","volume":"2","author":"K Schroeder","year":"2004","unstructured":"Schroeder K, Fahey T, Ebrahim S . Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev 2004; 2: CD004804.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFjhh2015103_CR32","doi-asserted-by":"publisher","first-page":"e80633","DOI":"10.1371\/journal.pone.0080633","volume":"8","author":"R Horne","year":"2013","unstructured":"Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V . Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS ONE 2013; 8: e80633.","journal-title":"PLoS ONE"},{"key":"BFjhh2015103_CR33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","volume":"31","author":"O Jung","year":"2013","unstructured":"Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens 2013; 31: 766\u2013774.","journal-title":"J Hypertens"},{"key":"BFjhh2015103_CR34","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/clinchem\/45.8.1224","volume":"45","author":"RL Fitzgerald","year":"1999","unstructured":"Fitzgerald RL, Rivera JD, Herold DA . Broad spectrum drug identification directly from urine, using liquid chromatography-tandem mass spectrometry. Clin Chem 1999; 45: 1224\u20131234.","journal-title":"Clin Chem"},{"key":"BFjhh2015103_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00216-008-2292-5","volume":"392","author":"M Mazzarino","year":"2008","unstructured":"Mazzarino M, de la Torre X, Botre F . A screening method for the simultaneous detection of glucocorticoids, diuretics, stimulants, anti-oestrogens, beta-adrenergic drugs and anabolic steroids in human urine by LC-ESI-MS\/MS. Anal Bioanal Chem 2008; 392: 681\u2013698.","journal-title":"Anal Bioanal Chem"},{"key":"BFjhh2015103_CR36","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.jchromb.2009.09.036","volume":"877","author":"GJ Murray","year":"2009","unstructured":"Murray GJ, Danaceau JP . Simultaneous extraction and screening of diuretics, beta-blockers, selected stimulants and steroids in human urine by HPLC-MS\/MS and UPLC-MS\/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 3857\u20133864.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"BFjhh2015103_CR37","unstructured":"Moffat A, Osselton D, Widdop B, Watts J Clarke's Analysis of Drugs and Poisons, 4th edn, Pharmaceutical Press: London, UK, 2011.."},{"key":"BFjhh2015103_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1517\/17425250903397381","volume":"6","author":"C Hocht","year":"2010","unstructured":"Hocht C, Bertera FM, Mayer MA, Taira CA . Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers. Expert Opin Drug Metab Toxicol 2010; 6: 199\u2013211.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"BFjhh2015103_CR39","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2174\/1381612820666141024151119","volume":"21","author":"A Zisaki","year":"2015","unstructured":"Zisaki A, Miskovic L, Hatzimanikatis V . Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches. Curr Pharm Des 2015; 21: 806\u2013822.","journal-title":"Curr Pharm Des"},{"key":"BFjhh2015103_CR40","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","volume":"10","author":"DE Morisky","year":"2008","unstructured":"Morisky DE, Ang A, Krousel-Wood M, Ward HJ . Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008; 10: 348\u2013354.","journal-title":"J Clin Hypertens"},{"key":"BFjhh2015103_CR41","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","volume":"336","author":"B Vrijens","year":"2008","unstructured":"Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M . Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114\u20131117.","journal-title":"BMJ"},{"key":"BFjhh2015103_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-pharmtox-011711-113247","volume":"52","author":"TF Blaschke","year":"2012","unstructured":"Blaschke TF, Osterberg L, Vrijens B, Urquhart J . Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 2012; 52: 275\u2013301.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFjhh2015103_CR43","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/HYPERTENSIONAHA.113.01452","volume":"62","author":"FE Fadl Elmula","year":"2013","unstructured":"Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjonnaess E, Hjornholm U et al. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Hypertension 2013; 62: 526\u2013532.","journal-title":"Hypertension"},{"key":"BFjhh2015103_CR44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/jme.2005.012138","volume":"32","author":"JS Chatterjee","year":"2006","unstructured":"Chatterjee JS . From compliance to concordance in diabetes. J Med Ethics 2006; 32: 507\u2013510.","journal-title":"J Med Ethics"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhh2015103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhh2015103","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhh2015103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:36:49Z","timestamp":1684431409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh2015103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFjhh2015103"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2015.103","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]},"assertion":[{"value":"5 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}